KRAS G12D Mutated Advanced Solid Tumors research hub

A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation

This study is testing a new medicine called ARV-806 for adults with advanced cancer. This cancer has a specific change in its genes, called the KRAS G12D mutation. Researchers want to see if the medicine is safe and how well people tolerate it.